dr
liam
pneumonia
cap
common
ill
potenti
especi
older
adult
comorbid
diseas
although
mani
microorgan
caus
cap
small
number
key
pathogen
caus
case
streptococcu
pneumonia
frequent
identifi
pathogen
highest
incid
organ
report
studi
use
urinari
antigen
detect
haemophilu
influenza
atyp
pathogen
mycoplasma
pneumonia
chlamydophila
pneumonia
legionella
pneumophila
virus
commonli
identifi
pathogen
cap
bacilli
enterobacteriacea
pseudomona
aeruginosa
caus
agent
patient
previou
antimicrobi
treatment
pulmonari
comorbid
bronchiectasi
copd
even
care
sought
prospect
studi
caus
organ
remain
unknown
half
patient
reason
failur
identifi
aetiolog
organ
includ
previou
antibiot
treatment
unusu
pathogen
go
unrecogn
viral
infect
pathogen
current
recogn
studi
conduct
japan
korea
thailand
show
aetiolog
cap
similar
report
west
except
low
incid
legionella
pneumonia
low
incid
legionella
infect
also
report
asian
countri
could
due
limit
laboratori
test
use
recent
surveil
studi
conduct
urban
tertiari
medic
centr
asia
involv
ambulatori
inpati
infect
rate
base
rise
antibodi
titr
acut
convalesc
sera
found
pneumonia
c
pneumonia
l
pneumophila
overal
infect
rate
atyp
pathogen
recent
studi
hospit
patient
l
pneumophila
identifi
case
pneumonia
c
pneumonia
often
caus
mild
clinic
diseas
therefor
patient
like
treat
outpati
similar
report
west
c
pneumonia
pneumonia
pneumonia
identifi
common
aetiolog
agent
ambulatori
patient
thai
studi
account
case
respect
studi
japan
show
almost
similar
find
number
studi
asia
preval
tuberculosi
high
shown
infect
due
mycobacterium
tuberculosi
commonli
present
cap
melioidosi
endem
asia
northern
australia
burkholderia
pseudomallei
consid
caus
organ
patient
cap
rural
asia
particularli
patient
diabet
mellitu
organ
identifi
hospit
cap
patient
khon
kaen
thailand
urban
bangkok
identifi
case
similarli
urban
part
malaysia
melioidosi
uncommon
howev
patient
admit
sever
cap
asia
b
pseudomallei
common
caus
organ
especi
patient
diabet
shown
studi
singapor
khon
kaen
asia
pacif
region
bacilli
h
influenza
klebsiella
pneumonia
frequent
isol
geograph
differ
microbiolog
cap
must
taken
consider
select
appropri
antibiot
initi
empir
therapi
cap
region
long
ago
asia
pacif
region
badli
affect
sever
acut
respiratori
syndrom
sar
caus
sar
coronaviru
region
like
rest
world
alway
vigil
possibl
outbreak
highli
pathogen
avian
influenza
practic
guidelin
normal
categor
cap
patient
base
site
treatment
outpati
gener
ward
intens
care
unit
presenc
comorbid
modifi
factor
eg
risk
pneumonia
patient
group
assign
list
like
pathogen
suggest
antimicrobi
therapi
provid
coverag
like
pathogen
resist
strain
sever
assess
made
basi
prognost
criteria
includ
patient
age
comorbid
physic
laboratori
radiograph
find
key
decid
initi
site
care
use
pneumonia
sever
index
psi
initi
risk
assess
endors
infecti
diseas
societi
america
canadian
infecti
diseas
societi
canadian
thorac
societi
australia
therapeut
guidelin
clear
correl
mortal
risk
class
risk
death
low
risk
class
intermedi
class
iv
high
class
v
howev
psi
may
practic
routin
use
busi
hospit
emerg
depart
primari
care
set
complic
requir
calcul
score
base
variabl
patient
demograph
gender
age
resid
comorbid
ill
initi
vital
sign
investig
result
psi
give
high
weight
patient
age
past
histori
lower
weight
potenti
import
clinic
featur
hypoxia
young
previous
well
patient
may
classifi
mild
cap
psi
class
despit
hypoxaem
clinic
sever
diseas
furthermor
psi
use
identifi
patient
may
safe
treat
outpati
rather
sever
cap
score
confus
elev
blood
urea
nitrogen
elev
respiratori
rate
low
systol
diastol
bp
age
year
altern
sever
assess
tool
simpler
patient
stratifi
group
accord
increas
risk
mortal
need
admiss
intens
care
focus
sever
episod
cap
rather
patient
past
histori
recent
updat
japanes
respiratori
societi
guidelin
recommend
use
modifi
version
score
includ
oxygen
satur
puls
oximetri
addit
paramet
howev
new
sever
score
system
need
evalu
prospect
studi
neither
psi
appear
particularli
use
predict
accur
whether
individu
patient
requir
intens
care
unit
admiss
recent
australian
studi
suggest
modifi
version
accur
purpos
yet
valid
recent
year
proport
penicillin
strain
pneumonia
level
penicillin
resist
increas
mani
asian
countri
resist
pneumonia
macrolid
also
preval
mani
asia
pacif
countri
fact
preval
rate
erythromycin
resist
exceed
sever
countri
howev
investig
found
increas
mortal
patient
infect
pneumonia
control
comorbid
ill
although
patient
infect
resist
organ
may
sever
diseas
suppur
complic
well
prolong
hospit
stay
despit
widespread
emerg
vitro
resist
current
antimicrobi
regimen
mostli
effect
treatment
pneumonia
cap
